CD79A and psoriasis: Similarly, there were no differences in the levels of tTG-IgA (p = 0.54), tTG-IgG (p = 0.49), AGA-IgA (p = 0.65) AGA-IgG (p = 0.40) between the psoriasis patients who used biological agents and the control group (Table 4).